The Coalition for Epidemic Preparedness Innovations (CEPI) is a global organization that funds and supports the development of vaccines against infectious diseases that pose a threat to public health worldwide. CEPI works to accelerate vaccine development and ensure equitable access to vaccines in low- and middle-income countries (LMICs). Their mission is to reduce the impact of epidemics and pandemics through scientific collaboration, technology innovation, and equitable distribution of resources. CEPI collaborates with governments, private sector partners, and other international organizations to respond to outbreaks swiftly and effectively, ultimately enhancing global health security. CEPI’s focus is on advancing the development and manufacturing of vaccines, along with tools that help tackle epidemic and pandemic threats through innovative approaches.

CEPI has announced a funding opportunity aimed at developing innovative analytical technologies that will accelerate vaccine development, reduce costs, and enhance deployment. The focus is on technologies that improve vaccine release speed, minimize manufacturing costs, and make vaccines more accessible globally, particularly in LMICs. This funding supports the development of analytical tools that can streamline the vaccine manufacturing process, replace traditional assays, and improve vaccine characterization. Applicants will work on technologies like biosensors, PCR, and sequencing to minimize time and cost in the vaccine development cycle. Successful applicants will be awarded funding in two stages, with the aim of producing solutions that can be commercialized or adapted for vaccine production.